Skip to content

White Paper on OSSIOfiber Technology

← All Posts

Our proprietary material technology, OSSIOfiber® Intelligent Bone Regeneration Technology, has unique material composition and structural design that contribute to its strength and optimal bio-integration for orthopedic fixation. Scientific and clinical leaders at OSSIO discuss the science behind OSSIOfiber in this Technology Overview White Paper. 

Key Takeaways:

  • OSSIOfiber material composition creates the ideal bone fixation material that supports mechanical strength and balanced pH environment favorable for bone regeneration
  • The micro-architecture of thousands of continuous natural mineral fibers is engineered to create the optimal biomechanical properties in different mechanical axes for the clinical indications
  • As OSSIOfiber implants degrade, interconnected pores are formed allowing for fluid flow and regeneration of bone tissue in place of the implant
Screen Shot 2020-10-30 At 1.38.34 Pm

Through the material composition and internal architecture, OSSIOfiber is designed to provide both the mechanical strength required for insertion and secure fixation while having the ability to integrate into native bone without adverse inflammation. In doing so, OSSIOfiber Intelligent Bone Regeneration Technology creates a new category of fixation, called ‘Bio-Integratives’.

 

Learn more about material composition and structural design of OSSIOfiber Intelligent Bone Regeneration Technology.

 

Orahn Preiss-Bloom, Founder and Chief Innovation Officer

Orahn Preiss-Bloom, Founder and Chief Innovation Officer

Orahn is the Founder and Chief Innovation Officer at OSSIO. Previously, as founder and COO/CTO of LifeBond, Orahn developed two biosurgical product families to commercial stage and raised $60M, including from Johnson & Johnson Development Corporation. Prior, he was a biomechanics researcher at IDF Institute for Military Physiology and at Columbia University NY, Dept. of Orthopedic Surgery. Orahn has an M.Sc. in biomedical engineering from the Technion, Israel Institute of Technology.

Related Posts

Implant-related artifacts around metallic and bio-integrative screws: a CT scan 3D Hounsfield unit assessment

Christian VandeLune1, Tutku Tazegul1, Samuel J Ahrenholz1, Caleb Iehl1, Victoria Vivtcharenko1, Eli Schmidt1, Kevin N Dibbern1, Hee Young Lee1, Matthieu Lalevee1, Nacime Salomão Barbachan Mansur1, César de César Netto1 1. Department of Orthopedics and Rehabilitation, University of Iowa, Carver College of Medicine, Iowa City-IA, USA. Study performed at Department of Orthopedics and Rehabilitation, University ofContinue reading “Implant-related artifacts around metallic and bio-integrative screws: a CT scan 3D Hounsfield unit assessment”

Department of Orthopedics and Rehabilitation, University of Iowa, Carver College of Medicine, Iowa City-IA, USA. October 4, 2021

In Vivo Study of Bio-Integrative OSSIOfiber Plates

The performance and bio-integration of the OSSIOfiber® Intelligent Bone Regeneration Technology has been successfully evaluated for in-bone and soft tissue fixation. The purpose of this in vivo study was to further evaluate the OSSIOfiber® material properties when implanted over the surface of bone, for its bone-implant interface, local tissue response and full bio-integration profile. ThisContinue reading “In Vivo Study of Bio-Integrative OSSIOfiber Plates”

ASPS Webinar

Earn CECH credits by watching this recent webinar, hosted with American Society of Podiatric Surgeons and presenter Bob Baravarian, DPM, FACFAS.  NOW ON-DEMAND WEBINAR: The Science and Clinical Experience with Strong and Bio-Integrative Implant Fixation Speaker: Bob Baravarian, DPM, FACFAS   Hear Dr. Baravarian present on: Science behind the strong and bio-integrative OSSIOfiber Technology First-in-humanContinue reading “ASPS Webinar”

Bob Baravarian, DPM November 3, 2020

Interested in OSSIOfiber®?

Complete the form and an OSSIOfiber® Advisor will get in touch.

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email info@ossio.io

Address

Commercial Headquarters
OSSIO Inc
300 Tradecenter Drive, Suite 3690
Woburn, MA, 01801

Science & Manufacturing Center

OSSIO Ltd.
8 HaTochen Street
Cesarea, Israel 3079861

OSSIOfiber® has been used by surgeons across the US

Footnotes

1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO. 5.Haddad, S. F., Helm, M. M., Meath, B., Adams, C., Packianathan, N., & Uhl, R. (2019). Exploring the Incidence, Implications, and Relevance of Metal Allergy to Orthopaedic Surgeons. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 3(4), e023. https://doi.org/10.5435/JAAOSGlobal-D-19-00023